A quiet revolution is happening and genomic science is leading the charge. In-house counsel, trial attorneys, scientists, economists and law professors have recently recognized the broad applications of genomics in a wide variety of legal challenges. These thought leaders now accept that the state-of-the-science is mature enough to be a critical factor in developing a sound strategy for winning.
Silicone wristbands are being sold as personal exposure monitors to measure the so-called exposome – i.e., every chemical a person is exposed to over the course of a lifetime. Advances in genomic science are transforming our understanding of lung cancer, differentiating lung cancers in asbestos-exposed patients from lung cancer in asbestos unexposed patients. Genomic information is heavily influencing the types of warnings being made for pharmaceutical products.
A quiet revolution is happening and genomic science is leading the charge. In-house counsel, trial attorneys, scientists, economists and law professors have recently recognized the broad applications of genomics in a wide variety of legal challenges. These thought leaders now accept that the state-of-the-science is mature enough to be a critical factor in developing a sound strategy for winning.
In an effort to understand these compelling and emerging factors, ISS partnered with Gnarus Advisors and the LSP Group to sponsor an inter-disciplinary conference hosted by the Center for Law, Science & Innovation at Arizona State University in April 2016. The conference was titled:
How Emerging Science Intersects with Business, Law and Regulation To Create Risks and Opportunities
At this unique event, we enlisted engaging speakers from a variety of disciplines, including:
ISS was delighted to participate in such an innovative and cutting edge conference. We are actively engaged in thinking of venues to hold the conference next year and are eager to come up with topics that are equally engaging and inspiring.
Did you like this post? We are here to help! Schedule a consult with one of our experts.
Just fill out the form bellow and we will contact you with more information.
On Wednesday July 8, 2020, Dr. David Schwartz of Innovative Science Solutions presented at the IADC 2020 Virtual Annual Meeting on a panel titled The Use of Genetic Testing in the Courtroom. A complimentary copy of the panel presentation is now available for download. Read more
Dr. David Schwartz of Innovative Science Solutions will be presenting at the IADC 2020 Virtual Annual Meeting on a panel titled The Use of Genetic Testing in the Courtroom. Read more
Genetic Evidence Concerning Causation for Mesothelioma 16 June 2020 at 2pm Eastern Daylight Time. Read more
Plaintiff experts having been asserting for decades that all mesotheliomas must be linked to some asbestos exposure. Indeed, this has led to the erroneous (but widespread) view that mesothelioma is a signature disease, only caused by asbestos exposure. Read more
The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us today
Contact us